References

Unresolved reference

External reference

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

10.1056/nejmoa066254 · 2007 · External reference

Bariatric Surgery Versus Intensive Medical Therapy for Diabetes—5‐Year Outcomes

10.1056/nejmoa1600869 · 2017 · External reference

Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity

10.1001/jama.2022.9009 · 2022 · External reference

Long‐Term Mortality After Gastric Bypass Surgery

10.1056/nejmoa066603 · 2007 · External reference

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023

2025 · External reference

ASMBS Updated Position Statement on Insurance Mandated Preoperative Weight Loss Requirements

10.1016/j.soard.2016.04.019 · 2016 · External reference

Should Presurgical Psychological Evaluations Still Be a Mandated Requirement for Metabolic and Bariatric Surgery? A Critique of the Literature and Thoughts on Future Directions

10.1016/j.soard.2024.08.001 · 2024 · External reference

10.1037/14035-000

10.1037/14035-000 · 2013 · External reference

Tirzepatide Once Weekly for the Treatment of Obesity

10.1056/nejmoa2206038 · 2022 · External reference

Once‐Weekly Semaglutide in Adults With Overweight or Obesity

10.1056/nejmoa2032183 · 2021 · External reference

Definition and Diagnostic Criteria of Clinical Obesity

10.1016/s2213-8587(24)00316-4 · 2025 · External reference

10.1002/oby.24352

10.1002/oby.24352 · External reference

10.1177/20552076251382040

10.1177/20552076251382040 · External reference

10.1101/2025.03.06.25323524

10.1101/2025.03.06.25323524 · External reference

RWD166 Real‐World Utilization Pattern of GLP‐1 Receptor Agonists in German Outpatient Care

10.1016/j.jval.2025.09.2916 · 2025 · External reference

Unresolved reference

External reference

The Impact of Bias and Stigma on Patient Referral for Metabolic/Bariatric Surgery: An Algerian Experience

10.1007/s11695-025-07882-w · 2025 · External reference

Comprehensive Outcomes After Roux‐en‐Y Gastric Bypass With a Near‐Complete 15‐Year Follow‐Up

2024 · External reference

Payor Status Differences in 30‐Day and 1‐Year Outcomes After Primary Laparoscopic Bariatric Surgery

10.1016/j.soard.2025.01.015 · 2025 · External reference

The Role of Insurance Plan Design in Bariatric Surgery Utilization: A Systematic Review

2023 · External reference

Association of Insurance Plan Design With Metabolic and Bariatric Surgery Utilization and Outcomes

2024 · External reference

10.1111/obr.13796

10.1111/obr.13796 · External reference

10.1093/bjs/znae052

10.1093/bjs/znae052 · External reference

Life Expectancy After Bariatric Surgery in the Swedish Obese Subjects Study

10.1056/nejmoa2002449 · 2020 · External reference

Association of Metabolic‐Bariatric Surgery With Long‐Term Survival in Adults With and Without Diabetes: A One‐Stage Meta‐Analysis

10.1016/s0140-6736(21)00591-2 · 2021 · External reference

Bariatric Metabolic Surgery vs Glucagon‐Like Peptide‐1 Receptor Agonists and Mortality

10.1001/jamanetworkopen.2024.15392 · 2024 · External reference

Benefits and Risks of Bariatric Surgery in Adults: A Review

10.1001/jama.2020.12567 · 2020 · External reference

The Psychosocial Burden of Obesity

10.1016/j.ecl.2016.04.016 · 2016 · External reference

Patient Preferences for Weight Loss Treatments: A Discrete Choice Experiment

2024 · External reference

International Consensus Position Statement on the Role of Obesity Management Medications in the Context of Metabolic Bariatric Surgery

10.1093/bjs/znae283 · 2024 · External reference

Unresolved reference

External reference

A Cost Comparison of GLP‐1 Receptor Agonists and Bariatric Surgery: What Is the Break Even Point?

10.1007/s00464-024-11191-1 · 2024 · External reference

Cost‐Effectiveness of Endoscopic, Surgical and Pharmacological Obesity Therapies: A Microsimulation and Threshold Analyses

10.1136/gutjnl-2023-330437 · 2023 · External reference

Discontinuation of Glucagon‐Like Peptide‐1 Receptor Agonists

2024 · External reference

Discontinuation and Reinitiation of Dual‐Labeled GLP‐1 Receptor Agonists Among US Adults With Overweight or Obesity

10.1001/jamanetworkopen.2024.57349 · 2025 · External reference

GLP‐1RA in the Real World: 1‐Year Compliance and Outcomes of Semaglutide Use in Patients With or Without Previous History of Bariatric Surgery

2024 · External reference

Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension

10.1111/dom.14725 · 2022 · External reference

Weight Regain After Cessation of Medication for Weight Management: Systematic Review and Meta‐Analysis

10.1136/bmj-2025-085304 · 2026 · External reference

Variation by Race/Ethnicity in the Utilization and Weight Loss Following Metabolic Bariatric Surgery

10.1016/j.soard.2023.06.007 · 2023 · External reference

Influence of Referral Type and Sociodemographic Factors on Completion of Bariatric Surgery

10.1016/j.soard.2024.11.002 · 2025 · External reference

10.1016/j.soard.2025.01.008

10.1016/j.soard.2025.01.008 · External reference

10.1111/dom.70012

10.1111/dom.70012 · External reference